ARCHIVES

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

New Saccharin Studies Convince FDA It A Carcinogen

July 15, 1977

Gleevec Approved For Pediatric CML

May 23, 2003

Increased Breast Density Can Lead to Higher Risk

August 26, 2011

Former Group Chair Responds To Niederhuber: Change But Don’t Dissolve Cooperative Groups

July 2, 2010

Coalition Members Urged To Demand Intent Of Congress In Cancer Act Be Recognized

March 13, 1981

Congress Approves Payments For Treatment Of Women Diagnosed In CDC Program.

October 13, 2000